Get the Stockscreener App
1.67
1.76%
-0.03
After Hours:
1.65
-0.02
-1.20%
Inmune Bio Inc stock is traded at $1.67, with a volume of 255.85K.
It is down -1.76% in the last 24 hours and down -3.47% over the past month.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
See More
Previous Close:
$1.70
Open:
$1.7
24h Volume:
255.85K
Relative Volume:
0.64
Market Cap:
$44.40M
Revenue:
$155.00K
Net Income/Loss:
$-30.01M
P/E Ratio:
-1.00
EPS:
-1.67
Net Cash Flow:
$-11.98M
1W Performance:
-3.47%
1M Performance:
-3.47%
6M Performance:
-38.38%
1Y Performance:
-80.26%
1-Day Range:
$1.63
$1.70
1-Week Range:
$1.565
$1.72
52-Week Range:
$1.38
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Name
Inmune Bio Inc
Sector
Industry
Phone
(858) 964-3720
Address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Compare INMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.67 | 45.19M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.84 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.65 | 79.20B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
833.16 | 50.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
361.35 | 47.29B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
337.79 | 37.55B | 4.98B | 69.59M | 525.67M | 0.5197 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-01-25 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Oct-21-24 | Initiated | Alliance Global Partners | Buy |
| Sep-27-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Scotiabank | Sector Outperform |
| Jun-01-23 | Initiated | Robert W. Baird | Outperform |
| May-24-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jul-07-21 | Reiterated | Maxim Group | Buy |
| Apr-21-21 | Initiated | B. Riley Securities | Buy |
| Jan-22-21 | Reiterated | Maxim Group | Buy |
| Sep-01-20 | Initiated | BTIG Research | Buy |
| Jul-15-20 | Reiterated | H.C. Wainwright | Buy |
View All
Inmune Bio Inc Stock (INMB) Latest News
Aug PostEarnings: Is INmune Bio Inc stock undervalued right nowMarket Performance Recap & Long-Term Safe Investment Plans - baoquankhu1.vn
Sell Signal: Will Reading International Inc benefit from geopolitical trends2025 Trading Recap & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug Rallies: What is the earnings history of INmune Bio IncMarket Performance Report & Daily Technical Forecast Reports - baoquankhu1.vn
Is INmune Bio Inc. trading at a discountDay Trade & Reliable Price Breakout Alerts - bollywoodhelpline.com
Take Profit: Is Varex Imaging Corporation still a buy after recent gains - baoquankhu1.vn
INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial - MSN
INmune Bio, Inc. (NASDAQ:INMB) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Aug Breakouts: How liquid is INmune Bio Inc. stockJuly 2025 Momentum & Consistent Return Strategy Ideas - baoquankhu1.vn
How INmune Bio Inc stock reacts to bond yieldsQuarterly Market Review & Weekly High Return Opportunities - Bộ Nội Vụ
How interest rate cuts could boost INmune Bio Inc. stockTrail vs Road Selection & lightweight options for faster days - Улправда
Can INmune Bio Inc. stock deliver sustainable ROEBreakout Watch & High Conviction Investment Ideas - Улправда
Risk Recap: How INmune Bio Inc. stock reacts to bond yieldsJuly 2025 Trends & Risk Controlled Swing Trade Alerts - ulpravda.ru
Will INmune Bio Inc. stock outperform Dow Jones indexLayoff News & Expert-Curated Trade Recommendations - ulpravda.ru
Is INmune Bio Inc. stock a top pick in earnings seasonPortfolio Performance Report & Free Daily Entry Point Trade Alerts - ulpravda.ru
How INmune Bio Inc. stock benefits from strong dollar2025 Buyback Activity & Real-Time Buy Zone Alerts - ulpravda.ru
What hedge fund activity signals for INmune Bio Inc. stock2025 Volume Leaders & Safe Capital Growth Stock Tips - ulpravda.ru
Will INmune Bio Inc. stock benefit from automation2025 Market WrapUp & AI Based Trade Execution Alerts - ulpravda.ru
Is INmune Bio Inc. stock a good choice for value investorsTrade Risk Assessment & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
What is the fair value of INmune Bio Inc. stock nowTrade Volume Summary & AI Forecast Swing Trade Picks - ulpravda.ru
INmune Bio reverses early gains after stock offering - MSN
Energy Moves: Can INmune Bio Inc. stock deliver sustainable ROEMarket Risk Summary & Free Safe Capital Growth Stock Tips - Улправда
INmune Bio Inc.Common stock (NQ: INMB - FinancialContent
Is INmune Bio Inc. stock vulnerable to regulatory risksReal-Time Stock Alerts & Boost Wealth With Growth - Улправда
INmune Bio (INMB) price target decreased by 37.50% to 5.36 - MSN
Aug EndMonth: Will INmune Bio Inc stock outperform Dow Jones indexLong Setup & Verified Momentum Watchlists - moha.gov.vn
Can INmune Bio Inc. stock withstand economic slowdownEarnings Revision Updates & Breakout Portfolio Performance - ulpravda.ru
INMUNE BIO INC (INMB) Stock Technical Analysis - Chartmill
INmune Bio Inc Stock Analysis and ForecastTechnology Stock Trends & Exceptional Capital Growth - earlytimes.in
How INmune Bio Inc. stock performs in high volatility marketsEnergy Sector Updates & Small Investment Capital Tips - bollywoodhelpline.com
Inmune Bio Amends April 2024 Investor Warrants - TipRanks
INMB (INmune Bio) EV-to-OCF : -0.76 (As of Dec. 22, 2025) - GuruFocus
INMB (INmune Bio) EV-to-FCF : -0.75 (As of Dec. 22, 2025) - GuruFocus
Aug Wrap: How interest rate cuts could boost INmune Bio Inc stockQuarterly Earnings Summary & Real-Time Buy Signal Notifications - moha.gov.vn
Winners Losers: What is the fair value of INmune Bio Inc stock nowChart Signals & Accurate Trade Setup Notifications - moha.gov.vn
Gains Report: Is INmune Bio Inc stock a top pick in earnings seasonQuarterly Portfolio Review & Weekly Watchlist of Top Performers - moha.gov.vn
Why analysts upgrade INmune Bio Inc. stockMarket Performance Recap & Expert Curated Trade Ideas - Улправда
INmune Bio Establishes $65 Million At-The-Market Offering - The Globe and Mail
Will INmune Bio Inc. stock attract more institutional investorsLayoff News & Smart Money Movement Alerts - Улправда
Aug Highlights: Is INmune Bio Inc. stock attractive for long term wealth buildingWeekly Trading Summary & Verified Technical Trade Signals - Улправда
INMune Bio establishes $65 million at-the-market offering - MSN
INmune Bio Signs Sales Agreement With A.G.P./Alliance Global Partners - TradingView — Track All Markets
Is INmune Bio Inc. stock resilient to inflation2025 Fundamental Recap & Community Verified Trade Alerts - DonanımHaber
INmune Bio Shares Collapse After Mixed Results from Alzheimer’s Drug Trial - MSN
INmune Bio Earnings Notes - Trefis
INmune Bio (NASDAQ:INMB) Rating Increased to Hold at Wall Street Zen - MarketBeat
Aug Closing: Is INmune Bio Inc stock resilient to inflationTrade Risk Report & Expert Verified Movement Alerts - moha.gov.vn
Praetorian PR LLC Sells 863,000 Shares of INmune Bio, Inc. $INMB - MarketBeat
Inmune Bio to Host Q3 Results Conference Call - MSN
Inmune Bio Reports Q3 2025 Financial Results - MSN
Inmune Bio Inc Stock (INMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
16.87%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):